Update on yttrium-90-based radio-embolization for treatment of hepatocellular carcinoma

Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma

(2010) Brian I. Carr et al.   CANCER

First experience of hepatic radioembolization using microspheres labelled with yttrium-90 (TheraSphere): practical aspects concerning its implementation

(2009) Etienne Garin et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Yttrium-90 radioembolization in the management of liver tumors: expanding the global experience

(2009) Ahsun Riaz et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes

(2009) Riad Salem et al.   GASTROENTEROLOGY

Alpha-Fetoprotein Response After Locoregional Therapy for Hepatocellular Carcinoma: Oncologic Marker of Radiologic Response, Progression, and Survival

(2009) Ahsun Riaz et al.   JOURNAL OF CLINICAL ONCOLOGY

Optimization of Radioembolic Effect with Extended-shelf-life Yttrium-90 Microspheres: Results from a Pilot Study

(2009) Robert J. Lewandowski et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Comparison of Yttrium-90 Radioembolization and Transcatheter Arterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma

(2009) David A. Kooby et al.   JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY

Chemoembolization of Hepatocellular Carcinoma: Patient Status at Presentation and Outcome over 15 Years at a Single Center

(2008) Daniel B. Brown et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Design and Endpoints of Clinical Trials in Hepatocellular Carcinoma

(2008) Josep M. Llovet et al.   JNCI-Journal of the National Cancer Institute